FEA results meshes for 5N force. by Nathan L. Wright (18389458)

<i>Trem1^−/−</i> mice develop smaller inflammatory lesions and show decreased cellular infiltrates at <i>L. major</i> infection sites. by Benjamin Weber (509906)

ICAM-1 and TGFβ2 signal from muscle invasive UBC causes perforin downregulation. by Ciputra Adijaya Hartana (5474756)

IL-15 treatment results in decreased lipid deposition in 3T3-L1 mature adipocytes and IL-6 and KC production with increasing IL-15 treatment. by Nicole G. Barra (317230)

Decrease in PP2A activity increases phosphorylation of p38MAPK, pMAPKAPK2 and Hsp27 in CD133+ cells. by Shih-Pei Lin (117914)

NF-κB transcriptional activity, but not IκB degradation, is decreased in Lrrk2-KD cells. by Beomsue Kim (172914)

Full-length PRR expression increases and sPRR secretion decreases in the absence of PACE4 in mouse. by Amro H. Mohammad (15081540)

General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

Pathways of macrophages and neutrophils were decreased in Ad26.COV2.S vaccinated compared to sham unvaccinated hamsters. by Malika Aid (7303874)

“…<p><b>(A)</b> Sample-enrichment analysis (SLEA) of pathways of monocytes, macrophages M1 and M2 pathways, and neutrophils signaling at 4 dpi following SARS-CoV-2 challenge in vaccinated hamsters (shown in pink and blue colors), sham unvaccinated hamsters (shown in green) and in naïve control hamsters (shown in red). …”

Transcriptomic analysis of the long-lived and short-lived Atg1 over-expressing flies reveals decreased lipid metabolism. by Ivana Bjedov (75652)

Hsp72 overexpression decreases total NF-κB-p65 in resting cells and reduces steady state IκBα protein levels. by Patrick W. Sheppard (586664)

“…Data points for p65 are the averages from n = 5 independent measurements, each normalized with respect to the initial amount of p65 in untreated BV2 cells. …”

Overview regarding the used assays and observation time points. by Fabian Westhauser (5314436)

Residuals of the seven evaluated fitting equations. by Kai Roecker (847195)

Subjects:

Mean ± SD values for the parameters found when Eq. 8 (S1 Appendix) was used to model the relationship between time duration of movement (<i>t</i>_<i>dur</i>) and the weig... by Kai Roecker (847195)

Subjects:

Graphical description of the fitting parameters. by Kai Roecker (847195)

Subjects:

<i>HSpeed</i> results overview. by Kai Roecker (847195)

Subjects:

Groups of power-profile curve fittings. by Kai Roecker (847195)

Subjects:

Mean ± SD values for the parameters found with fittings of Eq. 8, S1 Appendix) to the relationship between time duration of movement (<i>t</i>_<i>dur</i>) and maximum hor... by Kai Roecker (847195)

Subjects:

Independence of the lower against the upper asymptotes. by Kai Roecker (847195)

Subjects:

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10^-5), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10^-5), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10^-22), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10^-71), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10^-28), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10^-12), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10^-10) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10^-17). …”